TRION Research GmbH
Biotechnology
-
Short facts
-
- Manufacturer
- Year founded not available
- 14 Employees (site)
- Turnover: <5m EUR
Products/services: TRION Research offers dedicated preclinical and clinical support, with a particular focus on immunomonitoring services, tumor biology analyses and antibody conjugation and supply. Drug Development, Antibody Production Service, Immune Therapy
Basic data
Company
TRION Research GmbH
Street
Am Klopferspitz 19
PC / City
82152 Planegg
County
Upper Bavaria
Phone
+49 89 700766-0
Fax
+49 89 700766-11
Homepage
Language skills
English, German
Profile/competences
Core competencies
Trion Research develops a new class of intact trifunctional antibodies (triomab®) which are specifically targeted at characteristic antigens of tumours, such as B-cell-lymphoma and malignant melanoma. The advantage of these trifunctional antibodies over conventional therapeutic approaches is the fact that they simultaneously activate two immunological cascades and are thus particularly effective in destroying tumour cells. Trion Research is further active in the development of pharmaceutical diagnostics, focussing on pharmacodynamic and pharmacokinetic analyses in immunotherapeutic clinical studies.
Key sectors / sub-sectors
- Biotechnology: Molecular diagnostics for humans
- Biotechnology: Technical services for biotechnology
NACE industries
- Other research and experimental development on natural sciences and engineering 72.19
- Other manufacturing n.e.c. 32.99
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available